Literature DB >> 14367543

Furadantin in Proteus bacilluria: preliminary communication.

S J HEFFERNAN, P W KIPPAX, W A PAMPLIN.   

Abstract

Entities:  

Keywords:  FURAN DERIVATIVES/therapeutic use; PROTEUS INFECTIONS

Mesh：

Substances：

Year:  1955        PMID： 14367543      PMCID： PMC1023769          DOI： 10.1136/jcp.8.2.123

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  4 in total

1.  Furadantin.

Authors:  G CARROLL; R V BRENNAN
Journal:  J Urol       Date:  1954-05       Impact factor: 7.450

2.  Furadantin in infections of the genito-urinary tract.

Authors:  C M NORFLEET; P R BEAMER; H M CARPENTER
Journal:  J Urol       Date:  1953-07       Impact factor: 7.450

3.  Disseminated aspergillosis and moniliasis associated with agranulocytosis and antibiotic therapy.

Authors:  N E RANKIN
Journal:  Br Med J       Date:  1953-04-25

4.  Development of Proteus and Pseudomonas infections during antibiotic therapy.

Authors:  E M YOW
Journal:  J Am Med Assoc       Date:  1952-07-26
  4 in total
  3 in total

1.  The sensitivity of Proteus to nitrofurantoin in vitro.

Authors:  P W KIPPAX
Journal:  J Clin Pathol       Date:  1957-05       Impact factor: 3.411

2.  Proteus infection of urinary tract, with special reference to treatment with nitrofurantoin.

Authors:  J E MIDDLETON
Journal:  Br Med J       Date:  1957-08-31

3.  Nitrofurantoin in chronic urinary infection associated with renal calculi.

Authors:  M G MCGEOWN
Journal:  Br Med J       Date:  1956-08-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.